Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Faropenem
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Faropenem is a Antibiotic drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Community-Acquired Pneumonia.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
January 31, 2025
Lead Product(s) : Faropenem
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable